Cholmin Kang

CholMin Kang, Jonghyun Chung, Amanpreet Kaurb et al.

Deep learning-based CT segmentation systems often achieve high accuracy on clean benchmark images, but their performance may degrade under heterogeneous clinical imaging conditions such as noise, resolution loss, contrast variation, intensity shift, and artifacts. This instability can limit reliable deployment in real-world medical imaging workflows. We propose Robustness via Augmented Multi-corruption Pipeline (RAMP), a robustness-oriented augmentation framework for CT segmentation. RAMP combines anatomically constrained spatial perturbations, CT intensity transformations, and stochastic multi-corruption composition to expose models to clinically plausible image degradation during training. Across two CT segmentation evaluation settings, RAMP achieved the strongest corrupted-image performance and the smallest clean-to-corrupted robustness gap. In the five-organ noisy evaluation benchmark, RAMP improved mean corrupted Dice from 0.610 to 0.753 and reduced the robustness gap from 0.264 to 0.064 compared with the nnU-Net baseline. In Abdomen1K, RAMP improved mean corrupted Dice from 0.633 to 0.789 and reduced the robustness gap from 0.290 to 0.070. Although RAMP did not achieve the highest clean-image Dice, it substantially mitigated worst-case segmentation collapse under severe image degradation. These results suggest that multi-corruption augmentation can serve as a practical pre-deployment strategy for improving the reliability of CT segmentation systems in heterogeneous clinical environments.

Cholmin Kang, Chunggi Lee, Heon Song et al.

Large annotated datasets have been a key component in the success of deep learning. However, annotating medical images is challenging as it requires expertise and a large budget. In particular, annotating different types of cells in histopathology suffer from high inter- and intra-rater variability due to the ambiguity of the task. Under this setting, the relation between annotators' variability and model performance has received little attention. We present a large-scale study on the variability of cell annotations among 120 board-certified pathologists and how it affects the performance of a deep learning model. We propose a method to measure such variability, and by excluding those annotators with low variability, we verify the trade-off between the amount of data and its quality. We found that naively increasing the data size at the expense of inter-rater variability does not necessarily lead to better-performing models in cell detection. Instead, decreasing the inter-rater variability with the expense of decreasing dataset size increased the model performance. Furthermore, models trained from data annotated with lower inter-labeler variability outperform those from higher inter-labeler variability. These findings suggest that the evaluation of the annotators may help tackle the fundamental budget issues in the histopathology domain